loadpatents
name:-0.029338121414185
name:-0.025578022003174
name:-0.0079400539398193
Grant-Young; Katharine A. Patent Filings

Grant-Young; Katharine A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grant-Young; Katharine A..The latest application filed is for "compounds useful as immunomodulators".

Company Profile
6.26.26
  • Grant-Young; Katharine A. - Madison CT
  • Grant-Young; Katharine A. - Vieques PR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds useful as immunomodulators
Grant 10,882,844 - Yeung , et al. January 5, 2
2021-01-05
Compounds useful as immunomodulators
Grant 10,745,382 - Yeung , et al. A
2020-08-18
1,3-dihydroxy-phenyl derivatives useful as immunomodulators
Grant 10,590,105 - Yeung , et al.
2020-03-17
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
Grant 10,538,555 - Miller , et al. Ja
2020-01-21
Compounds Useful As Immunomodulators
App 20190352280 - YEUNG; Kap-Sun ;   et al.
2019-11-21
1,3-dihydroxy-phenyl Derivatives Useful As Immunomodulators
App 20190185450 - YEUNG; Kap-Sun ;   et al.
2019-06-20
Compounds useful as immunomodulators
Grant 10,144,706 - Yeung , et al. De
2018-12-04
Immunomodulators
Grant 10,143,746 - Allen , et al. De
2018-12-04
Compounds Useful As Immunomodulators
App 20180057455 - YEUNG; KAP-SUN ;   et al.
2018-03-01
Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions
App 20170260237 - Miller; Michael Matthew ;   et al.
2017-09-14
Immunomodulators
App 20170252432 - Allen; Martin Patrick ;   et al.
2017-09-07
Compounds Useful As Immunomodulators
App 20170107202 - YEUNG; KAP-SUN ;   et al.
2017-04-20
Compound for the treatment of hepatitis C
Grant 9,556,162 - Yeung , et al. January 31, 2
2017-01-31
A Novel Compound for the Treatment of Hepatitis C
App 20160318912 - Yeung; Kap-Sun ;   et al.
2016-11-03
Compounds for the treatment of hepatitis C
Grant 8,722,688 - Yeung , et al. May 13, 2
2014-05-13
Compounds for the treatment of hepatitis C
Grant 8,536,338 - Pracitto , et al. September 17, 2
2013-09-17
Compounds for the Treatment of Hepatitis C
App 20130197012 - Yeung; Kap-Sun ;   et al.
2013-08-01
Compounds for the treatment of hepatitis C
Grant 8,354,410 - Yeung , et al. January 15, 2
2013-01-15
Compounds for the Treatment of Hepatitis C
App 20120316126 - Yeung; Kap-Sun ;   et al.
2012-12-13
Compounds for the treatment of hepatitis C
Grant 8,309,558 - Yeung , et al. November 13, 2
2012-11-13
Compounds for the treatment of hepatitis C
Grant 8,293,909 - Pracitto , et al. October 23, 2
2012-10-23
Compounds For The Treatment Of Hepatitis C
App 20120201783 - Yeung; Kap-Sun ;   et al.
2012-08-09
Compounds for the treatment of hepatitis C
Grant 8,198,449 - Pracitto , et al. June 12, 2
2012-06-12
Compounds for the treatment of hepatitis C
Grant 8,148,382 - Yeung , et al. April 3, 2
2012-04-03
Compounds for the Treatment of Hepatitis C
App 20120059019 - Yeung; Kap-Sun ;   et al.
2012-03-08
Compounds for the treatment of hepatitis C
Grant 8,048,887 - Yeung , et al. November 1, 2
2011-11-01
Compounds for the Treatment of Hepatitis C
App 20110256099 - Yeung; Kap-Sun ;   et al.
2011-10-20
Compounds for the treatment of hepatitis C
Grant 7,994,171 - Yeung , et al. August 9, 2
2011-08-09
HIV integrase inhibitors
Grant 7,893,055 - Walker , et al. February 22, 2
2011-02-22
Compounds for the Treatment of Hepatitis C
App 20100249094 - Yeung; Kap-Sun ;   et al.
2010-09-30
Compounds for the Treatment of Hepatitis C
App 20100184800 - Pracitto; Richard ;   et al.
2010-07-22
Compounds for the Treatment of Hepatitis C
App 20100093694 - Yeung; Kap-Sun ;   et al.
2010-04-15
Compounds for the Treatment of Hepatitis C
App 20100063068 - Pracitto; Richard ;   et al.
2010-03-11
Compounds for the treatment of Hepatitis C
Grant 7,547,690 - Gentles , et al. June 16, 2
2009-06-16
Compounds for the treatment of hepatitis C
Grant 7,541,353 - Gentles , et al. June 2, 2
2009-06-02
Compounds for the treatment of hepatitis C
Grant 7,541,352 - Yeung , et al. June 2, 2
2009-06-02
Compounds for the treatment of hepatitis C
Grant 7,521,444 - Bender , et al. April 21, 2
2009-04-21
Indolobenzazepine HCV NS5B inhibitors
Grant 7,473,688 - Bergstrom , et al. January 6, 2
2009-01-06
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
Grant 7,452,876 - Yeung , et al. November 18, 2
2008-11-18
Compounds for the Treatment of Hepatitis C
App 20080226591 - Gentles; Robert G. ;   et al.
2008-09-18
Compounds for the Treatment of Hepatitis C
App 20080226590 - Bender; John A. ;   et al.
2008-09-18
Compounds for the Treatment of Hepatitis C
App 20080227769 - Gentles; Robert G. ;   et al.
2008-09-18
Compounds for the Treatment of Hepatitis C
App 20080188458 - Yeung; Kap-Sun ;   et al.
2008-08-07
HIV Integrase Inhibitors
App 20080004265 - Walker; Michael A. ;   et al.
2008-01-03
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
App 20070287694 - Yeung; Kap-Sun ;   et al.
2007-12-13
Indolobenzazepine HCV NS5B inhibitors
App 20070078122 - Bergstrom; Carl P. ;   et al.
2007-04-05
Method of treating migraine headaches using calcitonin gene related peptide mimetics
App 20050222158 - Andres, Charles J. JR. ;   et al.
2005-10-06
Novel beta-turn mimetics as calcitonin gene related peptide receptor antagonists
App 20050209256 - Andres, Charles J. JR. ;   et al.
2005-09-22
Pyridopyrimidine derivatives as 5-HT6 antagonists
Grant 6,875,771 - Wu , et al. April 5, 2
2005-04-05
Pyridopyrimidine derivatives as 5-HT6 antagonists
App 20040019064 - Wu, Yong-Jin ;   et al.
2004-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed